ORIC Pharmaceuticals, Inc.

NASDAQ:ORIC

9.15 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Revenue 0000000
Cost of Revenue 1.0320.9660.8970.9710.90.9
Gross Profit -1.032-0.966-0.897-0.97-1-0.9-0.9
Gross Profit Ratio 0000000
Reseach & Development Expenses 85.17261.6856.85835.92122.84419.02619.126
General & Administrative Expenses 25.60825.08722.01313.4225.7253.3453.415
Selling & Marketing Expenses -1.03200000-0.9
SG&A 25.60825.08722.01313.4225.7253.3452.515
Other Expenses 050.0150.1770.2890.2330
Operating Expenses 110.7886.76778.87149.34328.56922.37121.641
Operating Income -110.78-91.767-78.871-74.186-28.569-22.371-22.541
Operating Income Ratio 0000000
Total Other Income Expenses Net 10.0832.6450.1560.4831.6860.2330.512
Income Before Tax -100.697-89.122-78.715-73.703-26.883-21.363-22.029
Income Before Tax Ratio 0000000
Income Tax Expense 02.355-1.03823.567-1.397-1.0080
Net Income -100.697-91.477-77.677-97.27-25.486-21.363-22.029
Net Income Ratio 0000000
EPS -1.96-2.31-2.05-4.43-0.85-1.12-0.74
EPS Diluted -1.96-2.31-2.05-4.43-0.85-1.12-0.74
EBITDA -109.748-81.767-78.871-24.5-27.541-21.468-21.641
EBITDA Ratio 0000000